TradesViz
Here’s what "consistency" actually looks like in the trenches. The main chart tracks the 10-trade EMA trend. Notice the volatility? The sharp drops? That’s just noise. Now look at the Equity Curve below. It’s hitting all-time highs. Takeaway: You can have ugly short-term streaks and still run a world-class system. Zoom out. 🔎
TradesViz
Do you thrive in chaos or calm? 🌪️ Some traders need wild price swings to make money; others get chopped up by them. The Technical Analysis vs ATR (Average True Range) dashboard answers the question: "How volatile should the stock be for me to trade it?" Stop trading stocks that don't move enough to pay you—or move too much for you to handle.
TradesViz
Don't row against the tide. 🌊 A stock doesn't move in a vacuum; it moves with its sector. The Sector Treemap gives you a bird's-eye view of where the money is flowing in your portfolio. In this visual audit, the Technology sector is a sea of red, with major losses in PINS and AMD. Meanwhile, Consumer Discretionary is powering the account with massive green blocks from TSLA and GM. Identify the strong sectors. Cut the weak ones.
TradesViz
The price of the stock isn't the only thing that moves your PnL. This feature lets you stress-test your position against the two silent killers of option value: Time and Volatility. Using the "IV%" and "Date" sliders at the bottom, you can simulate exactly how "Theta Decay" or an "IV Crush" will impact your profitability. Will holding through earnings destroy your premium? Drag the slider and find out before you commit capital. Predict the future. Protect your account.
TradesViz
🎉 New auto sync: Blofin accounts can now be auto-synced on TradesViz, along with a few other crypto exchanges. More auto-sync coming soon, along with cool new features 😎
TradesViz
Stop digging through spreadsheets. Just ask. 🗣️ Imagine having a quantitative analyst sitting next to you, ready to answer any question about your performance. With AI Trade Chat, you can simply type "list out my weakest account" and get an instant, data-driven audit. In this example, the AI identifies that "Trades 02" is underperforming with a Win Rate of 48.33% and a Profit Factor of 0.79. It doesn't just show the chart; it interprets the story behind the numbers. Turn your data into a conversation.
TradesViz
The Feb 10 technical screen highlighted strong, sustained participation across multiple sectors, confirming broad market momentum. In the **five‑day continuous volume expansion group**, $KELYB led with a 58.9% price gain and a massive 2.34 million‑percent volume surge, signaling aggressive reentry into thinly traded small caps. $XPO and $ARMU followed with 37%‑plus gains, supported by triple‑digit volume jumps, while $ARMG (+35.3%) and $CING (+34.1%) showed consistent liquidity expansion tied to biotech and growth themes. $PSNY and $FORM advanced about 28%, both backed by significant volume inflows, reinforcing institutional participation. Among the **14‑day uptrend names**, momentum remained firm across speculative and large‑cap names alike. $BTF (+267%) and $BNAI (+265%) led price performance, while $LITX (+117%) printed a 2,492% volume surge, confirming durable strength in EV and battery plays. $AZN, $ETHD, and $ETQ held steady 70–80% gains with sustained interest, while $CONI and $MOD extended their multi‑week climbs on expanding turnover. The alignment of persistent price increases with multi‑session volume confirmation demonstrates steady accumulation rather than short‑term speculation — a constructive signal of underlying market breadth heading deeper into February.
TradesViz
The Feb 10 options flow screen showed consistent strength in put‑side premium selling across major sectors, signaling steady institutional risk rotation rather than panic moves. $TSM led the activity with a 103% increase in put premium sold, totaling 7.5 million in flow. The accompanying trend chart showed price stability through the session, confirming controlled selling pressure rather than directional weakness. Behind it, $KD surged 14,966%, and $MAGS rose 12,268%, both reflecting sharp multi‑day expansions in put flow from minimal prior levels. $EEM and $NVDL recorded 5,244% and 2,443% jumps, showing broader engagement across international and derivative ETFs. Mid‑range increases came from $HIMS (+625%), $BRKB (+797%), $BE (+460%), $GEV (+928%), and $NFLX (+60%), confirming the flow was market‑wide rather than sector‑specific. The pattern — continuous two‑day rise in sold puts paired with price stability — indicates accumulation of short‑volatility exposure. Such coordinated selling generally reflects confidence in near‑term market resilience and institutional positioning for premium capture heading into mid‑February.
TradesViz
The Feb 10 options tape showed concentrated institutional rotations in metals, semiconductors, and megacap tech. $SCCO dominated the session with a cluster of large sweeps on the $120C line expiring Feb 20 2026, totaling over $85 million in premium across multiple prints. Combined flow across $115C and $120C strikes suggests aggressive premium selling and repositioning around copper exposure, aligning with a broader materials unwind. $TSLA followed with mixed two‑way activity on December 2028 $600P contracts, alternating buy and sell splits of $22 million, $14 million, and $12 million each. The sequence reflected delta and volatility adjustment rather than new directional bets. Smaller but notable trades hit the $340C line at $5.9 million and June 2027 $120P at similar sizing. $SHOP printed heavy sell‑side sweeps on the $135P and $140P expiries (April and May 2026), totaling roughly $22 million, signaling institutional profit‑taking or structured premium capture after strong downside runs. $LMT logged a $6.8 million split‑side call buy on the March 2026 $570C, maintaining steady defense‑sector participation. $SLV and $XOM each added mid‑sized trades—around $6 million per print—keeping metals and energy active in hedge rotation.
TradesViz
The Feb 10 earnings lineup features a heavyweight mix of healthcare, consumer, energy, and industrial leaders. AstraZeneca ($AZN) opens the pre‑market slate with a $595 billion market cap and $2.18 EPS estimate, setting the tone for global pharma. Coca‑Cola ($KO) follows at $339 billion and $0.56 EPS, providing a read on global consumer demand. S&P Global ($SPGI) adds a key financial data component with a $133 billion valuation and $4.32 EPS forecast, while BP ($BP) brings energy exposure at $101 billion and $0.57 EPS. CVS Health ($CVS) contributes healthcare‑retail visibility with $0.99 EPS on a $99 billion market cap, and Duke Energy ($DUK) rounds out the utility side with $1.51 EPS expected. After hours, Gilead ($GILD) reports with $1.83 EPS on $189 billion, and Welltower ($WELL) at $1.44 EPS on $134 billion, both providing clarity on biotech and healthcare real‑estate trends. Marriott ($MAR) at $89 billion and Spotify ($SPOT) at $86 billion finish the pre‑market roster, offering insights into travel recovery and digital streaming margins.
